Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01669629 · ClinicalTrials.gov registry record · NA

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
183
Enrollment target
10
Study locations

NCT01669629 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 183 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (31% lower). The trial reports 10 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01669629, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
183 participants
Enrollment target
10
Study locations

Study Summary

This is a one week 2x2 crossover study comparing delefilcon A with etafilcon A, with a primary hypothesis of comparing the handling of each lens. Additional secondary markers are measured looking at subjective comfort and vision of the lenses.

Conditions Studied

Interventions

  • DEVICE delefilcon A
  • DEVICE etafilcon A

Study Locations (10)

Arkansas

  • - Little Rock

Connecticut

  • - Bridgeport

Florida

  • - Tampa

Missouri

  • - Blue Springs

New York

  • - Vestal

North Carolina

  • - Raleigh

Pennsylvania

  • - Kittanning

Rhode Island

  • - Warwick

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2012-08
Est. Completion 2012-11
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01669629

The ClinicalTrials.gov registry entry for NCT01669629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (31% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which delefilcon A is the first listed.

NCT01669629 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Arkansas, Connecticut, Florida.

Frequently Asked Questions

What is clinical trial NCT01669629 about?

NCT01669629 is a clinical study titled "Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear". This is a one week 2x2 crossover study comparing delefilcon A with etafilcon A, with a primary hypothesis of comparing the handling of each lens. Additional secondary markers are measured looking at subjective comfort and vision of the lenses.

What is the current status of trial NCT01669629?

This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2012-08. Estimated completion is 2012-11.

What conditions does trial NCT01669629 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01669629?

The interventions under investigation include: delefilcon A (DEVICE), etafilcon A (DEVICE).

Who is sponsoring clinical trial NCT01669629?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01669629 being conducted?

This trial has 10 study locations across Arkansas, Connecticut, Florida, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.